Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

TransMedics (TMDX) Other Gross PP&E Adjustments (2018 - 2026)

TransMedics has reported Other Gross PP&E Adjustments over the past 8 years, most recently at $375.9 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments rose 20.43% year-over-year to $375.9 million; the TTM value through Dec 2025 reached $375.9 million, up 20.43%, while the annual FY2025 figure was $375.9 million, 20.43% up from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $375.9 million at TransMedics, up from $364.1 million in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at $375.9 million in Q4 2025 and troughed at -$8.3 million in Q2 2023.
  • A 5-year average of $143.4 million and a median of $81.7 million in 2022 define the central range for Other Gross PP&E Adjustments.
  • Biggest five-year swings in Other Gross PP&E Adjustments: plummeted 2127.3% in 2022 and later surged 3671.52% in 2024.
  • Year by year, Other Gross PP&E Adjustments stood at $11.5 million in 2021, then soared by 106.8% to $23.7 million in 2022, then skyrocketed by 666.89% to $182.0 million in 2023, then skyrocketed by 71.5% to $312.1 million in 2024, then grew by 20.43% to $375.9 million in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for TMDX at $375.9 million in Q4 2025, $364.1 million in Q3 2025, and $358.2 million in Q2 2025.